Alamar Biosciences

Alamar Biosciences is a precision proteomics company advancing early disease detection through its NULISA platform and ARGO HT System. NULISA (NUcleic acid Linked Immuno-Sandwich Assay) combines a sequential immunocomplex capture-and-release mechanism with next-generation sequencing readout to deliver attomolar sensitivity and high-plex multiplexing for protein biomarker discovery, validation, and translational research. The fully automated ARGO HT System processes up to 288 samples per batch with under 30 minutes of hands-on time, supporting large-cohort studies across neurology, immunology, and oncology. Alamar was surfaced as a portfolio company of Qiming and added to the API Evangelist network; it is a life-sciences instrument and assay provider rather than a public-API company, so this profile captures identity, published web surface, and domain-security posture. No public developer API, OpenAPI, or SDK surface was found.

Alamar Biosciences is profiled on the APIs.io network. Tagged areas include Company, Proteomics, Biomarker Discovery, Life Sciences, and Diagnostics.

Alamar Biosciences’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyProteomicsBiomarker DiscoveryLife SciencesDiagnosticsGenomicsNeurologyImmunologyOncology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alamarbio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: alamarbio
name: Alamar Biosciences
description: Alamar Biosciences is a precision proteomics company advancing early disease detection through its NULISA platform
  and ARGO HT System. NULISA (NUcleic acid Linked Immuno-Sandwich Assay) combines a sequential immunocomplex capture-and-release
  mechanism with next-generation sequencing readout to deliver attomolar sensitivity and high-plex multiplexing for protein
  biomarker discovery, validation, and translational research. The fully automated ARGO HT System processes up to 288 samples
  per batch with under 30 minutes of hands-on time, supporting large-cohort studies across neurology, immunology, and oncology.
  Alamar was surfaced as a portfolio company of Qiming and added to the API Evangelist network; it is a life-sciences instrument
  and assay provider rather than a public-API company, so this profile captures identity, published web surface, and domain-security
  posture. No public developer API, OpenAPI, or SDK surface was found.
url: https://raw.githubusercontent.com/api-evangelist/alamarbio/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://alamarbio.com/wp-content/uploads/2026/04/Frame-574.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Proteomics
- Biomarker Discovery
- Life Sciences
- Diagnostics
- Genomics
- Neurology
- Immunology
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://alamarbio.com
- type: Blog
  url: https://alamarbio.com/blog/
- type: Support
  url: https://alamarbio.com/contact-us/
- type: PrivacyPolicy
  url: https://alamarbio.com/privacy-policy/
- type: LLMsTxt
  url: llms/alamarbio-llms.txt
- type: DomainSecurity
  url: security/alamarbio-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence